Skip to main content

Table 1 Mean (SD) or median (interquartile interval) values of variables at baseline and after 9 months of lifestyle intervention in total sample

From: Associations of the TNF-alpha -308 G/A, IL6 -174 G/C and AdipoQ 45 T/G polymorphisms with inflammatory and metabolic responses to lifestyle intervention in Brazilians at high cardiometabolic risk

 

Baseline

9 months

p

Energy intake (kcal/day)

1814 (673)

1530 (558)

0.008

Total physical activity (min/wk)

186 (60, 262)

221 (70, 303)

0.007

Weight (kg)

78.6 (15.5)

76.7 (15.4)

0.005

Waist circumference (cm)

99.2 (12.3)

98.1 (12.0)

0.005

Fasting plasma glucose (mg/dL)

99.5 (11.5)

96.7 (12.5)

0.018

2-h plasma glucose (mg/dL)

119.3 (28.3)

113.1 (29.3)

0.009

Triglycerides (mg/dL)

155.0 (65.5)

151.3 (71.5)

0.491

Total cholesterol (mg/dL)

202.0 (43.6)

198.0 [3, 43]

0.238

HDL-c (mg/dL)

42.5 (12.4)

46.7 (12.5)

0.001

LDL-c (mg/dL)

128.0 (40.0)

121.0 (38.4)

0.063

Apolipoprotein B (mg/dL)

96.0 (22.6)

84.4 (24.0)

0.004

Apolipoprotein A1 (mg/dL)

136.7 (18.5)

141.1 (19.7)

0.005

Insulin* (uUl/L)

9.6 (5.6, 11.9)

6.6 (4.2, 9.9)

0.003

HOMA-IR**

2.1 (1.3, 2.9)

1.5 (1.0, 2.3)

0.008

Adiponectin* (ng/dL)

11.8 (7.5, 18.9)

16.3 (11.5, 19.8)

0.012

Interleukin 6* (pg/dL)

2.5 (1.3, 4.0)

3.4 (2.0, 5.5)

0.007

C-reactive protein* (mg/dL)

0.370 (0.165, 0.617)

0.255 (0.070, 0.602)

0.036

Tumor necrosis factor α** (pg/dL)

10.9 (9.0, 13.4)

8.8 (7.2, 10.5)

0.003

  1. *Log-transformed for analysis.
  2. **Non-parametric test.
  3. HOMA-IR: homeostatic model assessment for insulin resistance.